These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 1501651)

  • 1. Role of plasminogen-activator inhibitor type 1 in the pathogenesis and outcome of the hemolytic uremic syndrome.
    Bergstein JM; Riley M; Bang NU
    N Engl J Med; 1992 Sep; 327(11):755-9. PubMed ID: 1501651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of both coagulation and fibrinolysis in childhood hemolytic uremic syndrome.
    Van Geet C; Proesmans W; Arnout J; Vermylen J; Declerck PJ
    Kidney Int; 1998 Oct; 54(4):1324-30. PubMed ID: 9767551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prothrombotic coagulation abnormalities preceding the hemolytic-uremic syndrome.
    Chandler WL; Jelacic S; Boster DR; Ciol MA; Williams GD; Watkins SL; Igarashi T; Tarr PI
    N Engl J Med; 2002 Jan; 346(1):23-32. PubMed ID: 11777999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion.
    Ake JA; Jelacic S; Ciol MA; Watkins SL; Murray KF; Christie DL; Klein EJ; Tarr PI
    Pediatrics; 2005 Jun; 115(6):e673-80. PubMed ID: 15930195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human renal microvascular endothelial cells as a potential target in the development of the hemolytic uremic syndrome as related to fibrinolysis factor expression, in vitro.
    Louise CB; Obrig TG
    Microvasc Res; 1994 May; 47(3):377-87. PubMed ID: 8084301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of coagulation and fibrinolysis in childhood diarrhoea-associated haemolytic uraemic syndrome.
    Nevard CH; Jurd KM; Lane DA; Philippou H; Haycock GB; Hunt BJ
    Thromb Haemost; 1997 Dec; 78(6):1450-5. PubMed ID: 9423793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of recombinant human erythropoietin on fibrinolytic system in children on continuous ambulatory peritoneal dialysis.
    Gündüz Z; Kisaarslan FA; Düsünsel R; Poyrazoglu HM; Saraymen R; Per H
    Adv Perit Dial; 1999; 15():278-82. PubMed ID: 10682118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombin generation and fibrinolysis in the thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.
    Monteagudo J; Pereira A; Reverter JC; Pijoan J; Tusell J; Puig L; Ordinas A; Castillo R
    Thromb Haemost; 1991 Nov; 66(5):515-9. PubMed ID: 1803613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired fibrinolysis in obstructive jaundice--evidence from clinical and experimental studies.
    Colucci M; Altomare DF; Chetta G; Triggiani R; Cavallo LG; Semeraro N
    Thromb Haemost; 1988 Aug; 60(1):25-9. PubMed ID: 3142090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adult hemolytic-uremic syndrome. A review of 37 cases.
    Melnyk AM; Solez K; Kjellstrand CM
    Arch Intern Med; 1995 Oct; 155(19):2077-84. PubMed ID: 7575067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of coagulation and fibrinolysis in the pathogenesis of diarrhea-associated hemolytic uremic syndrome.
    Proesmans W
    Semin Thromb Hemost; 2001 Jun; 27(3):201-5. PubMed ID: 11446653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma inhibitor of glomerular fibrinolysis in the hemolytic-uremic syndrome.
    Bergstein JM; Kuederli U; Bang NU
    Am J Med; 1982 Sep; 73(3):322-7. PubMed ID: 6181678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated serum elastase and alpha-1-antitrypsin levels in hemolytic uremic syndrome.
    Kaplan BS; Mills M
    Clin Nephrol; 1988 Oct; 30(4):193-6. PubMed ID: 3265082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired fibrinolysis in the hemolytic-uremic syndrome of childhood.
    Menzel D; Levi M; Dooijewaard G; Peters M; ten Cate JW
    Ann Hematol; 1994 Jan; 68(1):43-8. PubMed ID: 8110878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The tissue factor and plasminogen activator inhibitor type-1 response in pediatric sepsis-induced multiple organ failure.
    Green J; Doughty L; Kaplan SS; Sasser H; Carcillo JA
    Thromb Haemost; 2002 Feb; 87(2):218-23. PubMed ID: 11858480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated tissue factor circulating levels in children with hemolytic uremic syndrome caused by verotoxin-producing E. coli.
    Kamitsuji H; Nonami K; Murakami T; Ishikawa N; Nakayama A; Umeki Y
    Clin Nephrol; 2000 May; 53(5):319-24. PubMed ID: 11305804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemolytic-uremic syndrome (HUS): a clinicopathological study of 15 cases.
    Tinaztepe K; Akkök N; Tinaztepe B
    Turk J Pediatr; 1993; 35(1):23-36. PubMed ID: 8236514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of octreotide on epidermal growth factor receptor, tissue plasminogen activator, and plasminogen activator inhibitor during intraperitoneal adhesion formation.
    Lai HS; Chen Y; Chang KJ; Chen WJ
    J Gastroenterol; 2003; 38(6):555-60. PubMed ID: 12825131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peritoneal dialysis in infants and children.
    Lattouf OM; Ricketts RR
    Am Surg; 1986 Feb; 52(2):66-9. PubMed ID: 3946937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hypofibrinolysis after venous occlusion in patients treated with long-term hemodialysis].
    Opatrný K; Vít L; Opatrná S; Sulková S; Bodláková B
    Cas Lek Cesk; 1994 May; 133(11):346-9. PubMed ID: 8004664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.